|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of metalloproteinases and issue inhibitors of metalloproteinases in human osteoblast-like cells:dif- ferentiation is associated with repression of metalloproteinase biosynthesis 显示文摘 | Rifas L Fausto A Scott M J | 1994 | Endocrinology1994，134，2： | 1 |
| 2 | Liver regeneration显示文摘 | Fausto N Campbell J S Riehle K J | 2000 | Hepatol2000，32，1： | 1 |
| 3 | Regulation of liver growth:Proto-oncogenes and transforming growth factors显示文摘 | Fausto N Janet E Mead J | 1989 | Lab Invest1989，60，1： | 1 |
| 4 | Antithrombotic treatment in chronic heart failure and sinus rhythm: Systematic review显示文摘AIM: To assess the efficacy and safety of antithrombotic drugs(antiplatelet or anticoagulant drugs) compared to no antithrombotic treatment or placebo in patients with heart failure(HF) and sinus rhythm. METHODS: We searched Medline and Cochrane Library for randomized controlled trials evaluating antithrombotic treatment and no antithrombotic treatment in patients with HF and sinus rhythm. Risk ratio(RR) and 95%CIs were estimated performing meta-analysis with random effects method. RESULTS: Two studies met the inclusion criteria: Heart failure Long-term Antithrombotic Study and Warfarin/Aspirin Study in Heart failure, with 336 patients and mean follow-up 1.8-2.25 years. Stroke risk was not reduced by acetylsalicylic acid(RR = 1.18, 95%CI: 0.17-8.15), oral anticoagulation(RR = 0.30, 95%CI: 0.03-2.65) or overall antithrombotic drugs(RR = 0.52, 95%CI: 0.10-2.74). Acetylsalicylic acid showed a significant increased risk of worsening HF(RR = 1.78, 95%CI: 1.08-2.92), while oral anticoagulation had no impact in this outcome(RR = 1.03, 95%CI: 0.61-1.75). Overall antithrombotic drugs showed a significant risk increase of major bleeding(RR = 6.99, 95%CI: 0.89-54.64). CONCLUSION: Best available evidence does not support the routine use of antithrombotic drugs in patients with HF and sinus rhythm. These drugs, particularly oral anti-coagulation has the hazard of increase significantly major bleeding risk. | Daniel Caldeira Inês Cruz Rita Calé Cristina Martins Helder Pereira Joaquim J Ferreira Fausto J Pinto Joo Costa | 2015 | World Journal of Meta-Analysis2015，3，1： | 1 |
| 5 | Liver regeneration显示文摘 | Fausto N Campbell J S Riehle K J | | 0，，1： | 1 |
| 6 | Liver regeneration显示文摘 | Fausto N Campbell J S Riehle K J | 2006 | Hepatology2006，43，21： | 1 |
| 7 | Epithelial and Pseudoepithelial Differentiation in Glioblastoma and Gliosarcoma显示文摘 | Fausto J Rodriguez Bernd W | 2008 | Cancer2008，113，： | 1 |
| 8 | Expression of metalloproteinases and issue inhibitors of metalloproteinases in human osteoblast-like cells : differentiation is associated with repression of metalloproteinase biosynthesis 显示文摘 | Rifas L Fausto A Scott M J | 1994 | Endocrinology1994，134，2： | 1 |
| 9 | Impaired insulin action in rats with non-insulin-dependent diabetes显示文摘 | Levy J Gavin JR Fausto A | 1984 | Diabetes1984，33，9： | 1 |
| 10 | The role of hepatocytes and oval cells in liver regeneration and repopulation显示文摘 | FAUSTO N CAMPBELL J S | | 0，，01： | 1 |
| 11 | The role of hepatocytes and oval cells in liver regeneration and repopulation显示文摘 | Fausto N Campbell J S | 2003 | Mech Dev2003，120，1： | 1 |
| 12 | Liver regeneration显示文摘 | Fausto N Campbell J S Riehle K J | 2006 | Hepatology2006，43，21： | 1 |
| 13 | In vivo response of hepatocytes to growth factors requires an initial priming stimulus 显示文摘 | Webber EM Godowski P J Fausto N | 1994 | Hepatology1994，19，2： | 1 |
| 14 | Regulation of liver growth:Protooncogenes and transforming growth factors显示文摘 | Fausto N Janet E Mead J | 1989 | Lab Invest1989，60，： | 1 |
| 15 | The role of hepatocytes and oval cells in liver regeneration and repopulation显示文摘 | Fausto N Campbell J S | 2003 | Mech Dev2003，120，： | 1 |
| 16 | Expression of and tissue inhibitors of in human osteoblast-likecells : differentiation is associated with repression of metalloproteinase biosynthesis 显示文摘 | Rifas L Fausto A metalloproteinases metalloproteinases Scott M J | 1994 | Endocrinology1994，134，1： | 1 |
| 17 | Liver regeneration显示文摘 | FAUSTO N CAMPBELL J S RIEHLE K J | 2006 | Hepatology2006，43，1： | 1 |
| 18 | ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited显示文摘 | J?rg D. Seebach Georg Stussi Jakob R. Passweg Fausto R. Loberiza James L. Gajewski Armand Keating Martin Goerner Philip A. Rowlings Pierre Tiberghien Gerald J. Elfenbein Robert Peter Gale Jon J. van Rood Vijay Reddy Eliane Gluckman Brian J. Bolwell Thomas | 2005 | Biology of Blood and Marrow Transplantation2005，，12： | 1 |
| 19 | Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides显示文摘 | Murthy N Campbell J Fausto N | 2003 | J Control Release2003，89，3： | 1 |
| 20 | The role of hepatocytes and oval cells in liver regeneration and repopulation显示文摘 | Fausto N Campbell J S | 2003 | Mechanisms of Development2003，120，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员